Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in PGEN — Precigen, Inc.

CIK 1390777 NEW YORK, NY
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,704,631
+$1,027,736 QoQ
Shares Held
474,497
+9.5% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. PGEN ranks #133 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in PGEN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,704,631 474,497
2026-03-31 $1,676,895 433,307
2025-12-31 $1,959,769 468,845
2025-09-30 $1,255,525 381,619
2025-06-30 $464,864 327,370
2025-03-31 $494,591 331,942
2024-12-31 $367,221 327,878
2024-09-30 $317,252 333,952
2024-06-30 $666,422 421,788
2024-03-31 $583,603 402,487
2023-12-31 $598,176 446,401
2023-09-30 $646,437 455,238
2023-06-30 $497,603 432,700
2023-03-31 $402,347 379,574
2022-12-31 $508,563 334,582
2022-09-30 $713,033 336,337
2022-06-30 $421,426 314,498
2022-03-31 $672,226 318,591
2021-12-31 $1,248,457 336,512
2021-09-30 $1,716,049 343,898
2021-06-30 $2,066,591 316,962
2021-03-31 $2,075,948 301,299
2020-12-31 $2,874,665 281,830
2020-09-30 $984,028 281,151
2020-06-30 $1,423,859 285,343
2020-03-31 $1,028,329 302,450